Wuhan Hiteck Biological Pharma Co Ltd Financial Flexibility Index
Wuhan Hiteck Biological Pharma Co Ltd financial flexibility index. Wuhan Hiteck Biological Pharma Co Ltd (300683) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥360.81K (operating CF CN¥-17.49 Million minus capex CN¥17.85 Million) represents 0% of total liabilities (CN¥393.09 Million). Explore Wuhan Hiteck Biological Pharma Co Ltd (300683) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Wuhan Hiteck Biological Pharma Co Ltd (2013–2025)
Financial flexibility index of Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2025. Historical Financial Flexibility Index trend for Wuhan Hiteck Biological Pharma Co Ltd across 13 annual periods. Check cash flow reinvestment rate of Wuhan Hiteck Biological Pharma Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Wuhan Hiteck Biological Pharma Co Ltd Financial Flexibility Index by Year (2013–2025)
Wuhan Hiteck Biological Pharma Co Ltd financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Wuhan Hiteck Biological Pharma Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Wuhan Hiteck Biological Pharma Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.06x | CN¥-26.00 Million | CN¥-76.54 Million | CN¥407.14 Million | ▼ -151.0% |
| 2024 | 0.13x | CN¥65.77 Million | CN¥22.69 Million | CN¥525.05 Million | ▼ -65.5% |
| 2023 | 0.36x | CN¥172.76 Million | CN¥5.31 Million | CN¥475.73 Million | ▼ -40.6% |
| 2022 | 0.61x | CN¥227.01 Million | CN¥53.03 Million | CN¥371.20 Million | ▼ -16.4% |
| 2021 | 0.73x | CN¥259.20 Million | CN¥12.09 Million | CN¥354.46 Million | ▲ +259.4% |
| 2020 | 0.20x | CN¥93.93 Million | CN¥-19.70 Million | CN¥461.62 Million | ▼ -53.6% |
| 2019 | 0.44x | CN¥179.18 Million | CN¥63.03 Million | CN¥409.03 Million | ▲ +74.2% |
| 2018 | 0.25x | CN¥112.09 Million | CN¥73.42 Million | CN¥445.77 Million | ▼ -36.6% |
| 2017 | 0.40x | CN¥105.33 Million | CN¥83.08 Million | CN¥265.62 Million | ▼ -19.7% |
| 2016 | 0.49x | CN¥165.91 Million | CN¥143.86 Million | CN¥335.87 Million | ▼ -21.5% |
| 2015 | 0.63x | CN¥173.51 Million | CN¥159.89 Million | CN¥275.74 Million | ▲ +10.3% |
| 2014 | 0.57x | CN¥151.05 Million | CN¥135.40 Million | CN¥264.78 Million | ▲ +14.9% |
| 2013 | 0.50x | CN¥92.54 Million | CN¥76.82 Million | CN¥186.42 Million | — |